THE EFFECT OF ADMINISTRATION OF PROPRANOLOL ON THE PHARMACOKINETICS OF ISOXICAM

被引:2
作者
CAILLE, G
LARIVIERE, L
LACASSE, Y
VEZINA, M
BESNER, JG
机构
关键词
D O I
10.1002/bdd.2510070109
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:63 / 69
页数:7
相关论文
共 9 条
[1]  
BORONDY PE, 1981, PHARMACOLOGIST, V23, P212
[2]   ANTI-INFLAMMATORY PROPERTIES OF ISOXICAM(4-HYDROXY-2-METHYL-N-[5-METHYL-3-ISOXOLYL-2H-1,2-BENZOTHIAZINE-3-CARBOXAMIDE 1,1-DIOXIDE]) [J].
DIPASQUALE, G ;
RASSAERT, C ;
RICHTER, R ;
WELAJ, P ;
GINGOLD, J ;
SINGER, R .
AGENTS AND ACTIONS, 1975, 5 (03) :256-263
[3]   ANTI-INFLAMMATORY ACTIVITY OF ISOXICAM IN COMBINATION WITH ASPIRIN OR D-PROPOXYPHENE [J].
DIPASQUALE, G ;
RASSAERT, C ;
WELAJ, P ;
TRIPP, L .
AGENTS AND ACTIONS, 1976, 6 (06) :748-754
[5]   ASPIRIN-CONTROLLED AND PLACEBO-CONTROLLED STUDY OF ISOXICAM IN THE TREATMENT OF RHEUMATOID-ARTHRITIS [J].
FOGARI, R ;
BONEBRAKE, RA .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1982, 12 (02) :165-169
[7]   DO BETA-BLOCKERS DIFFER IN THEIR EFFECTS ON HEPATIC-MICROSOMAL ENZYMES AND LIVER BLOOD-FLOW [J].
PARKER, G ;
DANESHMEND, TK ;
ROBERTS, CJC .
JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 24 (11-1) :493-499
[8]  
Rowland M, 1980, CLIN PHARMACOKINETIC
[9]   PHARMACOLOGY AND PHARMACOKINETICS OF ISOXICAM [J].
YAKATAN, GJ .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1982, 12 (02) :154-159